News

Novo Nordisk and a popular virtual health company are making Wegovy more accessible to millions of more Americans. Hims & ...
A grandma of 11 and a New Jersey man have joined the growing chorus of users of the wildly popular weight-loss drugs Ozempic ...
Novo Nordisk appears to be letting compounded GLP-1 bygones be bygones—at least, in one respect. | Novo Nordisk appears to be ...
Shares of Novo Nordisk ( NVO 3.94%) are up on Tuesday. The company's stock gained 3.9% as of 2:40 p.m. ET today and was up as ...
Hundreds of thousands of people flocked to these compounding firms when they didn't have enough money to afford the costly ...
Since launching its wildly popular weight-loss drug Wegovy in 2021, Novo Nordisk has raised its annual sales guidance several ...
A federal judge rejected a bid by compounding pharmacies to continue selling versions of weight-loss drug Wegovy and diabetes ...
Overall, Novo is expecting slower growth in 2025. The company is guiding for sales to rise between 16% and 24%, down from 26% ...